TLR7/8 agonist 4 hydroxy-PEG10-acid Catalog No.:M17695-C Dienogest significantly increases the cells

Dienogest significantly increases the cells in G0/G1 phase and reduces the cells in S phase and G2/M phase in 24 and 48 hours in the cultured endometriotic stromal cells

InChi: InChI=1S/C9H13N5O4/c10-9-13-7-5(8(18)14-9)12-3(1-11-7)6(17)4(16)2-15/h4

23-hexaoxo-2-thia-6

InChi: InChI=1S/C40H59NO11/c1-19-11-24-5-7-28-20(2)12-26(45-28)9-10-40-17-33-36(51-40)37-38(50-33)39(52-40)35-29(49-37)8-6-25(47-35)13-22(42)14-27-31(16-30(46-24)21(19)3)48-32(34(27)44-4)15-23(43)18-41/h19

TLR7/8 agonist 4 hydroxy-PEG10-acid Catalog No.:M17695-C Dienogest significantly increases the cellsTLR7 8 agonist 4 hydroxy PEG10 acid (compound 9) is a drug linker conjugate for ADC with potent antitumor activity by using TLR7 8 agonist 4 (HY 139018; a TLR7 8 agonist), linked via the cleavable ADC linker hydroxy PEG10 acid (HY 133307). Product information CAS Number: 2388520 17 8 Molecular Weight: 837. 01 Formula: C41H68N6O12 Chemical Name: 1 (4 {4 amino 2 butyl 1H imidazo[4, 5 c]quinolin 8 yl}piperazin 1 yl) 3, 6, 9, 12, 15, 18, 21, 24, 27, 30